MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
Advances in Wiring and Balloon Technology for Complex PCI
With Raghav Gattani, MD, and Lindsey Cilia, MD, FACC, FSCAI
The PERSEVERE Trial: Advancing Evidence in High-Risk PE
With Stavros V. Konstantinides, MD, PhD, and Nicolas Meneveau, MD, PhD
High-Risk Atherosclerotic Plaque: Defining Features and Assessment on Imaging
By Priyadarshini Dixit, MD; Sierra Fleming, MD; and Olga Toleva, MD, MPH
Management of Nodular Coronary Calcium
By Yasser M. Sammour, MD, MSc; Andrew Murphy, MD; Robert Nicholson, MD; and Pratik Sandesara, MD
Advancing Structural Heart Care With Automation and AI
With Haytham Allaham, MD; Megan Coylewright, MD, MPH, FACC, FSCAI; and Mukta Srivastava, MD